TNM staging of colorectal carcinoma: Issues and caveats

Seminars in Diagnostic Pathology

Volumn 29, Issue 3, 2012, Pages 142-153

  Shia, Jinru ^a   Klimstra, David S ^a   Bagci, Pelin ^b   Basturk, Olca ^a   Adsay, N Volkan ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

AJCC; Colon; Pathological interpretation; Rectum; Staging parameters

Indexed keywords

ANTINEOPLASTIC AGENT; PODOPLANIN;

ANUS CARCINOMA; ARTICLE; BASEMENT MEMBRANE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CELL DIFFERENTIATION; CELL VIABILITY; CLINICAL PROTOCOL; COLORECTAL CARCINOMA; CRITERION VARIABLE; DISEASE FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIGNET RING CARCINOMA; SURVIVAL RATE; TUMOR BIOPSY; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR VOLUME;

CARCINOMA; COLORECTAL NEOPLASMS; HUMANS; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC;

EID: 84867485337     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2012.02.001     Document Type: Article

References (54)

1. Dukes C.E. Cancer of the rectum: an analysis of 1000 cases. J Pathol Bacteriol 1940, 50:527-539.
2. Dukes C.E. The surgical pathology of rectal cancer. J Clin Pathol 1949, 2:95-98.
3. Dukes C.E. The relation of histology to spread in intestinal cancer. Br J Cancer 1950, 4:59-62.
4. AJCC Cancer Staging Manual 2009, Springer, New York. 7th ed. S. Edge, D.R. Byrd, M.A. Carducci (Eds.).
5. Fenoglio C.M., Kaye G.I., Lane N. Distribution of human colonic lymphatics in normal, hyperplastic, and adenomatous tissue. Its relationship to metastasis from small carcinomas in pedunculated adenomas, with two case reports. Gastroenterology 1973, 64:51-66.
6. Lan Y.T., Yang S.H., Li A.F., et al. Conflicting finding on intramucosal colon cancers based on national survival outcomes data. J Clin Oncol 2010, 28:e469. author reply e470.
7. Lewin M.R., Fenton H., Burkart A.L., et al. Poorly differentiated colorectal carcinoma with invasion restricted to lamina propria (intramucosal carcinoma): a follow-up study of 15 cases. Am J Surg Pathol 2007, 31:1882-1886.
8. Shia J., Klimstra D.S. Intramucosal poorly differentiated colorectal carcinoma: can it be managed conservatively?. Am J Surg Pathol 2008, 32:1586-1588. author reply 1588-1589.
9. Gunderson L.L., Jessup J.M., Sargent D.J., et al. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010, 28:264-271.
10. Kenney B.C., Jain D. Identification of lymphatics within the colonic lamina propria in inflammation and neoplasia using the monoclonal antibody D2-40. Yale J Biol Med 2008, 81:103-113.
11. Rahier J.F., De Beauce S., Dubuquoy L., et al. Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease. Aliment Pharmacol Ther 2011, 34:533-543.
12. Fogt F., Zimmerman R.L., Ross H.M., et al. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep 2004, 11:47-50.
13. Compton C., Fenoglio-Preiser C.M., Pettigrew N., et al. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000, 88:1739-1757.
14. Shepherd N.A., Baxter K.J., Love S.B. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997, 112:1096-1102.
15. Keshava A., Chapuis P.H., Chan C., et al. The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer. Colorectal Dis 2007, 9:609-618.
16. Gunderson L.L., Jessup J.M., Sargent D.J., et al. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol 2010, 28:256-263.
17. TNM Classification of Malignant Tumours 1997, Wiley-Blackwell, New York. 5th ed. L.H. Sobin, C. Wittekind (Eds.).
18. TNM Classification of Malignant Tumours 2002, Wiley, John & Sons, Inc., Hoboken, NJ. 6th ed. L.H. Sobin, C. Wittekind (Eds.).
19. Nagtegaal I.D., Quirke P., Schmoll H.J. Has the new TNM classification for colorectal cancer improved care?. Nat Rev Clin Oncol 2011, 9:119-123.
20. Washington M.K., Berlin J., Branton P.A., et al. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Arch Pathol Lab Med 2008, 132:1182-1193.
21. Shia J., McManus M., Guillem J.G., et al. Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol 2011, 35:127-134.
22. Park S.Y., Chang H.J., Kim D.Y., et al. Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy?. Histopathology 2011, 59:650-659.
23. de Campos-Lobato L.F., Dietz D.W., Stocchi L., et al. Clinical implications of acellular mucin pools in resected rectal cancer with pathologic complete response to neoadjuvant chemoradiation. Colorectal Dis 2010, 14:62-67.
24. Shia J., Wang H., Nash G., et al. Lymph node staging in colorectal cancer: revisiting the benchmark of at least 12 lymph nodes in R0 resection. J Am Coll Surg 2012, 214:348-355.
25. National Quality Forum Endorsed Commission on Cancer Measures for Quality of Cancer Care for Breast and Colorectal cancers National Cancer Database. http://www.facs.org/cancer/qualitymeasures.html.
26. Evans M.D., Barton K., Rees A., et al. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease. Colorectal Dis 2008, 10:157-164.
27. Rullier A., Laurent C., Capdepont M., et al. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol 2008, 32:45-50.
28. Morcos B., Baker B., Al Masri M., et al. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy. Eur J Surg Oncol 2010, 36:345-349.
29. Klos C.L., Shellito P.C., Rattner D.W., et al. The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery. Am J Surg 2010, 200:440-445.
30. Molavi D., Argani P. Distinguishing benign dissecting mucin (stromal mucin pools) from invasive mucinous carcinoma. Adv Anat Pathol 2008, 15:1-17.
31. Qizilbash A.H., Meghji M., Castelli M. Pseudocarcinomatous invasion in adenomas of the colon and rectum. Dis Colon Rectum 1980, 23:529-535.
32. Muto T., Bussey H.J., Morson B.C. Pseudo-carcinomatous invasion in adenomatous polyps of the colon and rectum. J Clin Pathol 1973, 26:25-31.
33. Byun T.J., Han D.S., Ahn S.B., et al. Pseudoinvasion in an adenomatous polyp of the colon mimicking invasive colon cancer. Gut Liver 2009, 3:130-133.
34. Compton C.C., Greene F.L. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004, 54:295-308.
35. Stewart C.J., Morris M., de Boer B., et al. Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival. Histopathology 2007, 51:372-378.
36. Panarelli N., Brandt S.M., Yantiss R.K. Serosal scraping of cancer specimens aids the detection of serosal penetration by invasive carcinoma. Mod Pathol 2011, 24(suppl):162A.
37. Puppa G., Sonzogni A., Colombari R., et al. TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Arch Pathol Lab Med 2010, 134:837-852.
38. Compton C.C. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med 2006, 130:318-324.
39. Washington M.K., Berlin J., Branton P., et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 2009, 133:1539-1551.
40. Kojima M., Nakajima K., Ishii G., et al. Peritoneal elastic laminal invasion of colorectal cancer: the diagnostic utility and clinicopathologic relationship. Am J Surg Pathol 2010, 34:1351-1360.
41. Baik S.H., Kim N.K., Lee Y.C., et al. Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer. Ann Surg Oncol 2007, 14:462-469.
42. Bernstein T.E., Endreseth B.H., Romundstad P., et al. Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg 2009, 96:1348-1357.
43. Nagtegaal I.D., Marijnen C.A., Kranenbarg E.K., et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002, 26:350-357.
44. Heald R.J., Husband E.M., Ryall R.D. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?. Br J Surg 1982, 69:613-616.
45. MacFarlane J.K., Ryall R.D., Heald R.J. Mesorectal excision for rectal cancer. Lancet 1993, 341:457-460.
46. Heald R.J. The "Holy Plane" of rectal surgery. J R Soc Med 1988, 81:503-508.
47. Shia J., Guillem J.G., Moore H.G., et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 2004, 28:215-223.
48. Shia J., Tickoo S.K., Guillem J.G., et al. Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol 2002, 26:863-872.
49. Rullier A., Laurent C., Vendrely V., et al. Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma. Am J Surg Pathol 2005, 29:602-606.
50. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994, 73:2680-2686.
51. Ruo L., Tickoo S., Klimstra D.S., et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002, 236:75-81.
52. Puppa G., Ueno H., Kayahara M., et al. Tumor deposits are encountered in advanced colorectal cancer and other adenocarcinomas: an expanded classification with implications for colorectal cancer staging system including a unifying concept of in-transit metastases. Mod Pathol 2009, 22:410-415.
53. Shia J., Ellis N.A., Paty P.B., et al. Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol 2003, 27:1407-1417.
54. Alexander J., Watanabe T., Wu T.T., et al. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 2001, 158:527-535.